Clinical Trials Directory

Trials / Unknown

UnknownNCT05220644

Management of Pain Respiratory Distress at the End of Life in Newborn Palliative Care in the Delivery Room

Management of Pain Respiratory Distress at the End of Life in Newborn Palliative Care in the

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
University Hospital, Strasbourg, France · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The newborn feels pain and the newborn at the end of life, in the delivery room, is potentially exposed to pain and respiratory distress. Protocols for the management of end-of-life symptoms in the delivery room are used in current practice with very few validation studies. The protocol used in delivery rooms in Alsace uses fentanyl and midazolam intranasally. It has been used for 3 years and seems to provide satisfactory relief to newborn babies. In doing so, it seems to reassure parents about the quality of support and it seems to meet the expectations of professionals in these anxiety-provoking contexts. Scientific validation of these practices would allow wider dissemination to other maternity teams.

Conditions

Interventions

TypeNameDescription
PROCEDUREProtocols for the management of end-of-life symptomsApplication of the care protocol and data collection

Timeline

Start date
2022-02-01
Primary completion
2022-02-01
Completion
2023-02-01
First posted
2022-02-02
Last updated
2022-02-02

Locations

4 sites across 1 country: France

Source: ClinicalTrials.gov record NCT05220644. Inclusion in this directory is not an endorsement.